Anglo French Drug & Industries donate Vestibulator to SRRC Mumbai to help children in need

June 18, 2022 23:35 IST | ANI Press Release
Tennis player James Blake
Abhay Kanoria, Chairman and MD, Anglo - French Drugs & Industries Limited inagurating the vestibulator at SRRC

Anglo-French Drug & Industries one of the leading pharmaceutical companies in India, donated a Vestibulator to SRCC, a children's hospital in Mumbai.

The Vestibulator will be used to aid in the recovery of children with neurological issues, especially those suffering from autism and cerebral palsy. The machine itself is unique and state-of-the-art and was custom-made by IIT for SRCC; it is only the second of its kind in Mumbai. It will help in meeting the needs of the lower economic strata parents whose children will need therapy for various medical issues.

The machine was officially inaugurated by Abhay Kanoria, Chairman and Managing Director, Anglo-French Drugs & Industries Ltd at the official inaugural ceremony held by SRCC Centre for Child Development on June 17 at their Mumbai hospital.

The machine was donated to the hospital to expand its services to cater to the needs of children who would need physiotherapy. By using the machine the hospital aims to help children to recover faster and better and go back to leading a healthier life, which always has been the AFDIL's mission when it comes to providing the best healthcare services.

Talking at the inaugural ceremony Abhay Kanoria, Chairman and Managing Director, Anglo-French Drugs & Industries Limited said, "As an organization, we are committed to provide whatever help possible to create a great healthcare ecosystem. The reason we chose to donate this particular machine is that we felt that there is little focus on the vestibular system and how fixing it can aid in the well-being of children with neurological disorders, the incidences of which are on the rise. Our contribution to SRCC is our first step towards it. We hope that by way of this machine the needy children will get the best in class services."

Anglo-French Drugs and industries are one of the leading names in the world of pharmaceuticals. We have a heritage of 99 years with over 300 products selling across the world. The company has market-leading brands in nutraceuticals, CNS, skin, and respiratory segments. Our family comprises nearly 1000 people, who work diligently to serve over 65,000 doctors, 50,000 chemists, and all our other affiliated parties. Our vision is to build on our strong heritage and values to deliver high-quality medication and services.

This story is provided by NewsVoir. ANI will not be responsible in any way for the content of this article.


(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)


Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor